Table 4.
Complications by CTD type.
| CTD Type | ||||||
|---|---|---|---|---|---|---|
| 
 | 
||||||
| Complication* | CTR, CTS | CTR, CTS (× 2) | CTS | Modified CTR | Modified CTR, CTS | P Value† | 
| PCO, n (%) | ||||||
| No | 4 (80.0) | 1 (100) | 1 (33.3) | 21 (39.6) | 4(80.0) | .0627 | 
| Yes | 1 (20.0) | 0 (0) | 2 (66.7) | 32 (60.4) | 1(20.0) | |
| UGH syndrome, n (%) | ||||||
| No | 5 (100) | 1 (100) | 3 (98.2) | 52 (98.1) | 5(100) | 1.0 | 
| Yes | 0 (0) | 0 (0) | 0 (1.8) | 1 (1.9) | 0(0) | |
| IOL dislocation, n (%) | ||||||
| No | 5 (100) | 1 (100) | 2 (66.7) | 51 (96.2) | 4(80.0) | .1451 | 
| Yes | 0 (0) | 0 (0) | 1 (33.3) | 2 (3.8) | 1(20.0) | |
CTD = capsular tension device; CTR = capsular tension ring; CTS = capsular tension segment; IOL = intraocular lens; PCO = posterior capsule opacification; UGH = uveitis–glaucoma–hyphema
n = number of eyes in specified group; all analyses were based on available data
Significant probability was associated with Fisher exact test of the null hypothesis that there was no association between CTD type and each complication; the assumption was made that in the overall sample, all operated eyes were independent observations